A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy

Completed · Phase 4

Conditions studied: Idiopathic Hypersomnia, Narcolepsy

In brief

This study will assess the safety and efficacy of JZP258 (XYWAV) on sleepiness, polysomnography, and functional outcomes in patients with idiopathic hypersomnia (IH) or narcolepsy.

Key facts

Study ID
NCT05875974
Run by
Jazz Pharmaceuticals
People needed
207
Starts
2023-07-27
Expected to finish
2025-03-13
Last updated by the study team
2025-07-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.